4
Changes in Ownership
ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-24-020378
Chief Fin. & Admin Officer sold 2,591 shares at $8.06 ($20,883)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| MELLETT PAUL J Chief Fin. & Admin Officer | 2024-12-06 | Sale 10b5-1 | −2,591 | $8.06 | $20,883 | 91,710 | D: show line 1 in the form |
| Open-market sales · 2,591 sh · avg $8.06 · $20,883 | |||||||
Loading xslF345X05/form4.xml…